Kolexia
Calugaru Valentin Oncologie radiothérapie
Calugaru Valentin
Oncologie radiothérapie
Clcc Institut Curie
Paris, France
147 Activités
1.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs de la tête et du cou Carcinome épidermoïde de la tête et du cou Carcinome épidermoïde Récidive tumorale locale Chordome Tumeurs de la base du crâne Carcinome adénoïde kystique Lésions radiques

Collaborateurs

Voir plus
Le Tourneau Christophe
Le Tourneau Christophe
Clcc Institut Curie, Paris, France
Feuvret Loïc
Feuvret Loïc
Hôpital Pierre Wertheimer, Bron, France
Dendale Remi
Dendale Remi
Clcc Institut Curie, Paris, France
Thariat Juliette
Thariat Juliette
Centre François-Baclesse, Caen, France

Industries

Voir plus
A+A
16 collaboration(s)
Dernière en 2022
B3TSI
13 collaboration(s)
Dernière en 2023
WorldOne
2 collaboration(s)
Dernière en 2020
P\S\L Group Services
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION): A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Essai Clinique (Emd Serono)   05 mars 2024
Efficacy of Protontherapy in Atypical Meningiomas
ASTRO 2023: 65th Annual Meeting   01 octobre 2023
887P Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial
ASTRO 2023: 65th Annual Meeting   01 octobre 2023
Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure.
International journal of radiation biology   21 août 2023
Radiotherapy of rare head and neck tumors.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   16 août 2023
Antero-Lateral Approach and Vertebral Artery Transposition for a Giant Cervical Spine Chordoma With Bilateral Extension: 2-Dimensional Operative Video.
Operative neurosurgery (Hagerstown, Md.)   11 juillet 2023
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]   31 mai 2023
Proton therapy and/or helical tomotherapy for locally advanced sinonasal skull base adenoid cystic carcinoma: Focus on experience of the Institut Curie and review of literature.
Head & neck   25 avril 2023
Protontherapy to maintain local control of head and neck paragangliomas.
Acta oncologica (Stockholm, Sweden)   19 avril 2023